Search Results - "LEJEUNE, Laurence"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice by Eliopoulos, Nicoletta, Stagg, John, Lejeune, Laurence, Pommey, Sandra, Galipeau, Jacques

    Published in Blood (15-12-2005)
    “…It has been suggested that marrow stromal cells (MSCs) may be immunoprivileged and can engraft in allogeneic recipients with intact immune systems. We…”
    Get full text
    Journal Article
  2. 2

    Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy by Stagg, John, Lejeune, Laurence, Paquin, André, Galipeau, Jacques

    Published in Human gene therapy (01-06-2004)
    “…Marrow stromal cells (MSCs) can be easily gene-modified and clonally expanded making them ideal candidates for transgenic cell therapy. However, recent reports…”
    Get more information
    Journal Article
  3. 3

    Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways by Perri, Sabrina R, Martineau, Daniel, François, Moïra, Lejeune, Laurence, Bisson, Louis, Durocher, Yves, Galipeau, Jacques

    Published in Molecular cancer therapeutics (01-02-2007)
    “…Proteolytic processing of human plasminogen generates potent antiangiogenic peptides such as angiostatin. The plasminogen kringle 5 (K5) domain, which is…”
    Get full text
    Journal Article
  4. 4

    A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells by Jaalouk, Diana E, Lejeune, Laurence, Couture, Clément, Galipeau, Jacques

    Published in Virology journal (21-11-2006)
    “…T-cell activation leads to signaling pathways that ultimately result in induction of gene transcription from the interleukin-2 (IL-2) promoter. We hypothesized…”
    Get full text
    Journal Article
  5. 5
  6. 6

    CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization by Copland, Ian, Sharma, Kapil, Lejeune, Laurence, Eliopoulos, Nicoletta, Stewart, Duncan, Liu, Peter, Lachapelle, Kevin, Galipeau, Jacques

    Published in Experimental hematology (2008)
    “…Objective CD34 is a sialomucin often expressed by cells with hemangiopoietic potential and widely serves as a surrogate marker of stem cell potential…”
    Get full text
    Journal Article
  7. 7

    A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex by Rafei, Moutih, Wu, Jian Hui, Annabi, Borhane, Lejeune, Laurence, François, Moïra, Galipeau, Jacques

    Published in Blood (01-03-2007)
    “…We hypothesized that a granulocyte macrophage colony-stimulating factor (GMCSF) and interleukin 15 (IL-15) fusokine (GIFT15) would possess greater…”
    Get full text
    Journal Article
  8. 8

    Human-Compatible Collagen Matrix for Prolonged and Reversible Systemic Delivery of Erythropoietin in Mice from Gene-Modified Marrow Stromal Cells by Eliopoulos, Nicoletta, Lejeune, Laurence, Martineau, Daniel, Galipeau, Jacques

    Published in Molecular therapy (01-10-2004)
    “…Bone marrow stromal cells (MSCs) can be exploited therapeutically in transgenic cell therapy approaches. Our aim was to determine if gene-modified MSCs…”
    Get full text
    Journal Article
  9. 9

    Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression by PERRI, Sabrina R, NALBANTOGLU, Josephine, ANNABI, Borhane, KOTY, Zafiro, LEJEUNE, Laurence, FRANCOIS, Moira, DI FALCO, Marcos R, BELIVEAN, Richard, GALIPEAU, Jacques

    Published in Cancer research (Chicago, Ill.) (15-09-2005)
    “…Angiostatin, a well-characterized angiostatic agent, is a proteolytic cleavage product of human plasminogen encompassing the first four kringle structures. The…”
    Get full text
    Journal Article
  10. 10

    A GMCSF & IL15 Fusokine Leads to Paradoxical Immunosuppression In Vivo Via Asymmetrical JAK/STAT Signalling through the IL15 Receptor Complex by Rafei, Moutih, Wu, Jian Hui, Annabi, Borhane, Lejeune, Laurence, Francois, Moira, Galipeau, Jacques

    Published in Blood (16-11-2006)
    “…Immune stimulatory cytokines can be exploited to treat human ailments including cancer. Amongst cytokines identified for such use, granulocyte-macrophage…”
    Get full text
    Journal Article
  11. 11

    911. MHC Class I and II Mismatched Marrow Stromal Cells from C57Bl/6 Mice Are Immune Rejected by Recipient Balb/c Mice by Eliopoulos, Nicoletta, Stagg, John, Lejeune, Laurence, Galipeau, Jacques

    Published in Molecular therapy (01-05-2004)
    “…Bone marrow stromal cells (MSCs) can be easily harvested, culture expanded, and genetically engineered, and thus can be utilized therapeutically in…”
    Get full text
    Journal Article
  12. 12

    Human CD4 Expression at the Late Single-Positive Stage of Thymic Development Supports T Cell Maturation and Peripheral Export in CD4-Deficient Mice by Boyer, Olivier, Marodon, Gilles, Cohen, Jose L, Lejeune, Laurence, Irinopoulou, Theano, Liblau, Roland, Bruneval, Patrick, Klatzmann, David

    Published in The Journal of immunology (1950) (15-10-2002)
    “…Positive selection of developing thymocytes is initiated at the double-positive (DP) CD4(+)CD8(+) stage of their maturation. Accordingly, expression of a human…”
    Get full text
    Journal Article
  13. 13

    Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease by Cohen, J L, Saron, M F, Boyer, O, Thomas-Vaslin, V, Bellier, B, Lejeune, L, Charlotte, F, Klatzmann, D

    Published in Human gene therapy (10-12-2000)
    “…The main complications following allogeneic hematopoietic stem cell transplantation are graft-versus-host disease and poor immune reconstitution leading to…”
    Get more information
    Journal Article
  14. 14

    Immunological defects after suicide gene therapy of experimental graft-versus-host disease by Cohen, J L, Lacroix-Desmazes, S, Charlotte, F, Lejeune, L, Martin, P J, Klatzmann, D, Boyer, O

    Published in Human gene therapy (01-11-1999)
    “…Donor T cells are beneficial for engraftment, immune reconstitution, and antileukemic effects after allogeneic marrow transplantation, but they also cause…”
    Get more information
    Journal Article
  15. 15

    Position-dependent variegation of a CD4 minigene with targeted expression to mature CD4+ T cells by Boyer, O, Zhao, JC, Cohen, JL, Depetris, D, Yagello, M, Lejeune, L, Bruel, S, Mattei, MG, Klatzmann, D

    Published in The Journal of immunology (1950) (01-10-1997)
    “…The CD4 gene follows a complex and highly regulated pattern of expression throughout T cell development. This expression is governed by different regulatory…”
    Get full text
    Journal Article
  16. 16

    Fertile homozygous transgenic mice expressing a functional truncated Herpes simplex thymidine kinase ΔTK gene by COHEN, J. L, BOYER, O, KLATZMANN, D, SALOMON, B, ONCLERCQ, R, DEPETRIS, D, LEJEUNE, L, DUBUS-BONNET, V, BRUEL, S, CHARLOTTE, F, MATTEÏ, M.-G

    Published in Transgenic research (01-09-1998)
    “…Dividing cells expressing the Herpes simplex type 1 thymidine kinase (TK) can be killed upon ganciclovir treatment. Likewise, conditional cell knock-out can be…”
    Get full text
    Journal Article
  17. 17

    Fertile Homozygous Transgenic Mice Expressing a Functional Truncated Herpes Simplex Thymidine Kinase [Delta]TK Gene by Cohen, Jose L, Boyer, Olivier, Salamon, Benoit, Onclercq, Rosine, Depetris, Daniele, Lejeune, Laurence, Dubus-bonnet, Vanessa, Bruel, Sylvie, Charlotte, Frederic, Mattei, Marie-genevieve, Klatzmann, David

    Published in Transgenic research (01-08-1998)
    “…Dividing cells expressing the Herpes simplex type 1 thymidine kinase (TK) can be killed upon ganciclovir treatment. Likewise, conditional cell knock-out can be…”
    Get full text
    Journal Article